Oncimmune Holdings plc (LON:ONC – Get Free Report) shares fell 2.5% on Thursday . The stock traded as low as GBX 8 ($0.10) and last traded at GBX 9.95 ($0.12). 378,794 shares changed hands during trading, an increase of 34% from the average session volume of 281,822 shares. The stock had previously closed at GBX 10.20 ($0.13).
Oncimmune Stock Performance
The stock has a market cap of £7.00 million, a price-to-earnings ratio of -314.57 and a beta of 1.19. The company’s fifty day simple moving average is GBX 13.81 and its two-hundred day simple moving average is GBX 14.84. The company has a debt-to-equity ratio of 806.85, a current ratio of 1.13 and a quick ratio of 0.63.
About Oncimmune
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Further Reading
- Five stocks we like better than Oncimmune
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Must-Have ETFs Set to Dominate This Quarter
- Are Penny Stocks a Good Fit for Your Portfolio?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- The 3 Best Retail Stocks to Shop for in August
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
